PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Vitae London is a fashion brand producing water-resistant, stainless steel casing, and high-quality watches. For every watch sold, the company supports a South African child by providing all the resources they need for education. Vitae London has sold its products in over 30 countries and has distributed over 2,000 items of school uniform to children in need. It has been featured in CNN and BBC, and has been endorsed by Pharrell Williams, Richard Branson and many more high-profile names. The company is raising funds to make key hiring, launch US fulfilment site, and drive marketing channels.
days to go:
Expired
investment:
£109,536
Ruby Violet (RV) creates ice cream flavours, vegan sorbets and iced delights. It asserts that it has grown from a market stall in 2011, to two parlours and an accompanying vintage van, tricycle and trolley, almost doubling its revenue from 2016 to 2019. RV aims to become a contender in the ice cream industry that is worth £1.4 billion in the UK and £44 billion worldwide. It asserts that 90% of the packaging used by the company is either recyclable or compostable. It has featured in press entities like The Times, The Guardian, Vogue and the BBC, to name a few. RV has also collaborated with noted gin company, Gin Mare, creating gin ice cream and sorbet specific to their infused botanicals. RV's clients include Costa Coffee, Nike, McVitie's, and Moet & Chandon. It will use 75% of the investment for capital expenditure, 15% for marketing activities, and 10% for hiring key personnel.
days to go:
Expired
investment:
£357,173
Fightback is a beer and cider brand on a mission to save music venues with support from across the live music industry. The company claims that every pint sold contributes to Music Venue Trust (MVT), a UK-registered charity, which acts to protect, secure, and improve Grassroots Music Venues. It argues that it has sold 10,000 pints and 10,000 cans in 61 venues before the COVID-19 lockdown. Fightback asserts that it has agreed on a new national distribution deal to make the brand more accessible amidst the lockdown. It intends to supply 900+ venues affiliated with MVT when venues reopen. Fightback will use the investment to roll out beer and cider to help secure the long-term future of the venues that ensure that the music culture is kept alive.
days to go:
Expired
investment:
£52,596
JOHNNY'S is an ethical, vegan, and sex-positive subscription condom brand. The company aims to deliver its products on a subscription basis, following in the footsteps of Direct-To-Consumer (DTC) health disruptors like Harry's and Dollar Shave Club. It aims to become a contender in the global condom market that is set to be worth $15 Billion by 2026 and enter the lubricant and sex toy market later in 2021. The company has also pledged to give a condom to HIV/STI/NHS clinics for each condom sold. It will use the investment for a PR launch, social media advertising, stock purchase, and attract talent to help the business hit its growth targets.
days to go:
Expired
investment:
£182,281
GreenPiP produce sustainably sourced, green packaging for the packaging market. Their packaging will be made of just one material and therefore it is easier for the agencies that deal with recycling once it has been discarded.
days to go:
Expired
investment:
£105,000
Medics2You's is a hybrid telehealth platform that connects patients with healthcare experts around the globe with focus on Africa through a smart device from anywhere, six days a week. The company has a pilot project underway in Nigeria, a nation which spends $500m-1bn annually on outbound healthcare tourism. Medics2You aims to reach out to over 100m people unable to access quality healthcare. Medics2You's partnership with Lantum has given the company access to 18000+ doctors and 3000 clinicians. The funds will be used to create the web portal, expand the team, set up local centres, and enhance marketing activities.
days to go:
Expired
investment:
£156,370
